Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference
Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference
The following is a summary of the Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript:
以下是Moolec Science SA（MLEC）2024年第三季度業績電話會議記錄的摘要：
Financial Performance:
財務業績：
Revenue increased year-over-year from nil to approximately $1.3 million.
Gross margin stood at 18%.
Operational cash flow was approximately $2.7 million with a decrease in cash utilization year-over-year.
Moolec's cash position strengthened by approximately $2 million due to additional funding.
收入同比增長從零增加到約130萬美元。
毛利率爲18％。
運營現金流約爲270萬美元，現金利用率同比下降。
由於額外的資金，Moolec的現金狀況增加了約200萬美元。
Business Progress:
業務進展：
Achieved USDA-APHIS regulatory approval for Piggy Sooy.
Initiated field trials for Piggy Sooy in three different U.S. locations.
GLASO is in pre-commercial stages with intended market penetration in 2025.
Two U.S. patents granted for SPC2 technology extending protection till 2041.
Piggy Sooy 獲得了美國農業部動植物檢驗局的監管批准。
在美國三個不同地點啓動了 Piggy Sooy 的實地試驗。
GLASO處於商業前階段，計劃在2025年進入市場。
SPC2技術獲得了兩項美國專利，將保護期延長至2041年。
Opportunities:
機會：
Moolec's Piggy Sooy provides a sustainable alternative to traditional livestock farming, reducing water and CO2 emissions.
Expected commercial adoption and scaling of Piggy Sooy and GLASO in the forthcoming years.
Moolec 的 Piggy Sooy 爲傳統畜牧業提供了可持續的替代方案，減少了水和二氧化碳的排放。
預計Piggy Sooy和GLASO將在未來幾年得到商業採用和擴展。
Risks:
風險：
Dependence on the success and commercial acceptance of Piggy Sooy and other products still in pre-commercial or early commercial stages.
依賴於 Piggy Sooy 和其他仍處於商業前或早期商業階段的產品的成功和商業接受度。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。